Literature DB >> 19287181

Tripterygium wilfordii Hook F treatment for idiopathic refractory nephrotic syndrome in adults: a meta-analysis.

Gaosi Xu1, Weiping Tu, Dongfeng Jiang, Chengyun Xu.   

Abstract

Tripterygium wilfordii Hook F (TwHF) is a Chinese herbal medicine with immunosuppressive effects and an established history of use in the treatment of inflammatory and autoimmune diseases. We have carried out a meta-analysis of randomized controlled trials (RCTs) and quasi-RCTs which assessed the effectiveness of TwHF in the treatment for idiopathic refractory nephrotic syndrome (IRNS). After reading the full text, only three RCTs or quasi-RCTs meeting our inclusion criteria were selected. Our meta-analysis indicated that TwHF has beneficial effects on the remission of IRNS. There was no significant publication bias in the meta-analysis studies. However, studies with a larger sample size and including patients with both a mild and severe histopathological change involvement separately are needed to assess the effects of TwHF in IRNS patients before exact conclusions can be drawn. Copyright (c) 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287181     DOI: 10.1159/000208990

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  10 in total

Review 1.  Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseases.

Authors:  Rui Han; Martin Rostami-Yazdi; Sascha Gerdes; Ulrich Mrowietz
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 2.  Targeting tumor proteasome with traditional Chinese medicine.

Authors:  Huanjie Yang; Jinbao Liu; Q Ping Dou
Journal:  Curr Drug Discov Technol       Date:  2010-03

3.  Clinical outcomes in children with Henoch-Schönlein purpura nephritis grade IIIa or IIIb.

Authors:  Yonghui Xia; Jianhua Mao; Yifang Chen; Dayan Wang; Lu Cao; Shenhua Yao; Haidong Fu; Lizhong Du; Ai'min Liu
Journal:  Pediatr Nephrol       Date:  2011-03-09       Impact factor: 3.714

4.  Efficacy of triptolide for children with moderately severe Henoch-Schönlein purpura nephritis presenting with nephrotic range proteinuria: a prospective and controlled study in China.

Authors:  Li Wu; Jianhua Mao; Xia Jin; Haidong Fu; Huijun Shen; Jingjing Wang; Aimin Liu; Qiang Shu; Lizhong Du
Journal:  Biomed Res Int       Date:  2013-12-18       Impact factor: 3.411

5.  Safety Profiles of Tripterygium wilfordii Hook F: A Systematic Review and Meta-Analysis.

Authors:  Chi Zhang; Ping-Ping Sun; Hong-Tao Guo; Yan Liu; Jian Li; Xiao-Juan He; Ai-Ping Lu
Journal:  Front Pharmacol       Date:  2016-11-08       Impact factor: 5.810

Review 6.  Traditional Chinese Medicine for Refractory Nephrotic Syndrome: Strategies and Promising Treatments.

Authors:  Xiao-Qin Wang; Lan Wang; Yuan-Chao Tu; Yuan Clare Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-04       Impact factor: 2.629

Review 7.  A PRISMA-compliant systematic review and network meta-analysis on the efficacy between different regimens based on Tripterygium wilfordii Hook F in patients with primary nephrotic syndrome.

Authors:  Xin-Bin Wang; En-Lai Dai; Guo-Zhong Xue; Rui-Ling Ma
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

8.  Tripterygium wilfordii multiglycosides combined with prednisone in the treatment of idiopathic membranous nephropathy: A protocol for a systematic review and meta-analysis.

Authors:  Yuxia Jin; Jiayuan Zhang; Yunxia Wang; Xiao Xiao; Qi Zhang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

9.  Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria.

Authors:  Yuanyuan Guo; Ningning Guo; Jin Wang; Ruiqiang Wang; Lin Tang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

10.  Comparison of tripterygium wilfordii multiglycosides and tacrolimus in the treatment of idiopathic membranous nephropathy: a prospective cohort study.

Authors:  Shanshan Liu; Xiayu Li; Heng Li; Qian Liang; Jun Chen; Jianghua Chen
Journal:  BMC Nephrol       Date:  2015-12-04       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.